Style de citation APA (7e éd.)

Jimbu, L., Mesaros, O., Neaga, A., Nanut, A. M., Tomuleasa, C., Dima, D., . . . Zdrenghea, M. (2021). The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia. MDPI AG.

Style de citation Chicago (17e éd.)

Jimbu, Laura, Oana Mesaros, Alexandra Neaga, Ana Maria Nanut, Ciprian Tomuleasa, Delia Dima, Corina Bocsan, et Mihnea Zdrenghea. The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia. MDPI AG, 2021.

Style de citation MLA (8e éd.)

Jimbu, Laura, et al. The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia. MDPI AG, 2021.